Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.7500 (2.86%) ($36.4000 - $38.0000) on Mon. Aug. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 37 | Latest Price | $37.7500(2.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.73% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
1 - 5 Day Possible Target | $29.78(-21.11%) | Resistance Level | $38.67 | 5 Day Moving Average | $37.21(1.45%) | 10 Day Moving Average | $37.48(0.72%) | 20 Day Moving Average | $38.67(-2.38%) | To recent high | -26.6% | To recent low | 5.3% | Market Cap | $2.805b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |